Riccardo Polosa on Ecig Evidence
Riccardo Polosa makes a presentation on ecig evidence at the GFN
-
by Dave Cross
Share on:
He began by introducing the work he did with Doctor Konstantinos Farsalinos where they looked at the effect of vaping on the blood pressure of smokers making the switch. “Blood pressure is a common problem for many people,” he said while point out that this could be a way to bring “allies” into the vape debate. Their work, as we covered here on Planet Of The Vapes, demonstrated a reversal of blood pressure problems when people used an electronic cigarette to quit smoking.
Further investigation demonstrated that vaping was strongly linked to smoking cessation, not something that the team highlighted at the time. This further avenue of enquiry also highlighted significant changes in systolic and diastolic blood pressure reading for the better. “This is something that is not good news to the drug industry,” he took pleasure in adding.
Not good news for the drug industry because the data demonstrated that ecigs were more effective at controlling blood pressure in patients with a historical medical problem than their previous medication.
Evidence of improvement in hypertension was recorded in 1149 individuals, representing half of the subjects. Meanwhile 40% demonstrated no change through adverse effects. All told, Polosa stated that vaping lowers blood pressure, works at improving blood pressure control in hypertension patients, displayed positive results even for those dual-fuelling and offers a “helpful alternative to cigarettes”.
He went on to speak about the improvements vaping lends to the respiratory system. Coughing and wheezing were reported also as being reduced in those switching to ecigs. Turning to asthma, Polosa talked about the improvement in “quality of life” for those suffering from the affliction, countering the lies made about vaping increasing the chances of attacks. The COPD data tells the same tale of improvements in life quality after switching to electronic cigarettes.
Then Riccardo moved on to the subject of where nicotine can help in the treatment of medical conditions. As a much-maligned drug, it offers huge potential as a therapeutic tool in the management of Parkinson’s, ulcerative colitis, depression, schizophrenia, ADHD and mild cognitive impairment.
Dave Cross
Journalist at POTVDave is a freelance writer; with articles on music, motorbikes, football, pop-science, vaping and tobacco harm reduction in Sounds, Melody Maker, UBG, AWoL, Bike, When Saturday Comes, Vape News Magazine, and syndicated across the Johnston Press group. He was published in an anthology of “Greatest Football Writing”, but still believes this was a mistake. Dave contributes sketches to comedy shows and used to co-host a radio sketch show. He’s worked with numerous start-ups to develop content for their websites.
Join the discussion
Parliament Fears Two
The Department for Environment, Food and Rural Affairs faced questions from a Conservative MP and, oddly, a member of the Department for Environment, Food and Rural Affairs
-
by Dave Cross
Harm Reduction For The Rich
The United Kingdom risks becoming a harm reduction country only for the wealthy, according to Michael Landl of the World Vapers’ Alliance
-
by Dave Cross
Sacrificing Health For 2p Cut
Tory Government alienates vaping voters with its mission to cut tax by an unaffordable 2p to attract voters by placing a tax on vape products in the forthcoming budget
-
by Dave Cross
Scotland Announces Single-Use Vape Action
A ban on the sale and supply of single-use vapes in Scotland is due to come into effect on 1 April 2025, under proposed legislation published today
-
by Dave Cross
-listing400.jpg)
